Pregled bibliografske jedinice broj: 946901
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits // Nature Communications, 9 (2018), 1; 2601-2601 doi:10.1038/s41467-018-04900-7 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 946901 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
Autori
Park, Solip ; Supek, Fran ; Lehner, Ben
Izvornik
Nature Communications (2041-1723) 9
(2018), 1;
2601-2601
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
genomics ; mutation ; cancer
Sažetak
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-scale tumor sequencing has revolutionized the identification of somatic driver alterations but has had limited impact on the identification of cancer predisposition genes (CPGs). Here we present a statistical method, ALFRED, that tests Knudson’s two-hit hypothesis to systematically identify CPGs from cancer genome data. Applied to ~10, 000 tumor exomes the approach identifies known and putative CPGs – including the chromatin modifier NSD1 – that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH). Rare germline variants in these genes contribute substantially to cancer risk, including to ~14% of ovarian carcinomas, ~7% of breast tumors, ~4% of uterine corpus endometrial carcinomas, and to a median of 2% of tumors across 17 cancer types.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Interdisciplinarne prirodne znanosti, Informacijske i komunikacijske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
- Nature Index